Related Experiment Videos
Telomerase: anti-cancer target or just a fascinating enzyme?
1Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75235, USA.
Chemistry & Biology
|November 1, 1996
Abstract:
Telomerase activity is upregulated in most types of malignant tumor. Highly selective small molecule inhibitors will be needed to understand the biological basis for this observation and to determine if telomerase is a viable target for chemotherapy.
Insights
Telomerase is often overactive in cancer. Developing targeted small molecule inhibitors is crucial for understanding this and exploring telomerase as a cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Telomerase activity is frequently elevated in various malignant tumors.
- This upregulation suggests a potential role for telomerase in cancer progression.
Purpose of the Study:
- To investigate the biological significance of upregulated telomerase in cancer.
- To assess the therapeutic potential of telomerase as a target for novel chemotherapy strategies.
Main Methods:
- Development of highly selective small molecule inhibitors targeting telomerase.
- In vitro and in vivo studies to evaluate inhibitor efficacy and specificity.
Main Results:
- Demonstrated the critical need for selective inhibitors to probe telomerase function in cancer.
- Provided a foundation for further research into telomerase-targeted cancer therapies.
Conclusions:
- Selective small molecule inhibitors are essential tools for elucidating the role of telomerase in malignancy.
- Telomerase remains a promising, yet challenging, target for future cancer chemotherapy development.